BTS: MW X Vikrant Massey

It’s safe to say this — Vikrant Massey is now a star. From primetime television to mainstream cinema, not to mention the back-to-back OTT releases in the past few years, Massey has made it clear that for him, there’s nowhere to go but to the top. Read the full interview here.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
‘Misleading’ to compare countries’ foodborne illness data, say experts thumbnail

‘Misleading’ to compare countries’ foodborne illness data, say experts

Comparing foodborne illness rates between countries can be misleading because of differences in methodology and data sources, according to a study. Foodborne illness estimation models are country-specific, making international comparisons problematic. Some disparities in estimated rates can be attributed to variations in methodology rather than real differences in risk, said scientists. Researchers looked at foodborne
Read More
9.4 confirmed cases per 100,000 people in Seoul…  Is there a possibility of re-extension of the current distance? thumbnail

9.4 confirmed cases per 100,000 people in Seoul… Is there a possibility of re-extension of the current distance?

당국, 내달 4일부터 적용할 '사회적 거리두기' 조정안 놓고 고심중현 유행 추세라면 방역 수위 완화하긴 쉽지 않을 수도백신 접종 완료자 인센티브 확대 방안도 검토 연합뉴스 국내 신종 코로나바이러스 감염증(코로나19) 4차 대유행이 석 달 가까이 이어지고 있으나 거센 확산세로 인해 여전히 끝을 알 수 없는 상황이 계속되고 있다. 주말·휴일을 거치면서 2천200명대로 떨어졌던 하루 신규 확진자는 주 중반에…
Read More
Dupilumab Effective for Up To 1 Year in Teens With AD: Study thumbnail

Dupilumab Effective for Up To 1 Year in Teens With AD: Study

Serious adverse events remained rare and skin remained largely clear in adolescents treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis (AD) for up to 52 weeks in a phase 3 open-label extension trial, researchers reported. At 1 year, 86% of 50 remaining patients with weights under 60 kg (132 lb) had achieved 75% improvement (EASI-75;…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share